Rh Isoimmunization and Other Blood Group Incompatibilities — MCQs
A 3rd gravida with normal previous two pregnancies. What is the best test to diagnose Rh sensitization in an Rh-negative mother?
Anti-D prophylaxis is MOST critically indicated in which of the following situations?
Under the Anaemia Mukt Bharath initiative, mild to moderate anaemia in pregnant women <34 weeks of gestation is treated using:
What are the criteria for administering Anti-D immunoglobulin postpartum in an Rh-negative female?
Fetomaternal transfusion of fetal RBCs in mother can be detected by: UPSC 08; TN 08; AIIMS 10
In an Rh-negative mother who has delivered an Rh-positive baby, prophylactic anti-D is indicated for:
A G2P1L1 female presents at 28 weeks of gestation with a 1:4 anti-D titre. What is the most appropriate management option?
Consider the following statements regarding pregnancy with Rh isoimmunization: 1. Indirect coombs test is performed in mother 2. Methergin is withheld at delivery of anterior shoulder 3. Middle cerebral artery peak systolic velocity is an accurate method to predict fetal anemia Which of the statements given above are correct?
Which one of the following statements regarding Rh isoimmunization is correct? 1. Liley's chart identifies anemia better than middle cerebral artery Doppler 2. Indirect Coombs test is positive in mother 3. Baby is at risk of developing anemia 4. Direct Coombs test is positive in baby
One day after delivery, an African American female newborn develops yellow discoloration of the eyes. She was born at term via uncomplicated vaginal delivery and weighed 3.4 kg (7 lb 8 oz). Her mother did not receive prenatal care. Examination shows scleral icterus and mild hepatosplenomegaly. Laboratory studies show: Hemoglobin 10.7 g/dL Reticulocytes 3.5% Maternal blood group O, Rh-negative Fetal blood group A, Rh-negative Serum bilirubin, total 6.1 mg/dL Serum bilirubin, direct 0.4 mg/dL Which of the following is the most likely cause of this patient's condition?
Rh Isoimmunization and Other Blood Group Incompatibilities Indian Medical PG Practice Questions and MCQs
Question 1: A 3rd gravida with normal previous two pregnancies. What is the best test to diagnose Rh sensitization in an Rh-negative mother?
- A. Direct Coombs' test
- B. Rh Antigen test
- C. Indirect Coombs' test (Correct Answer)
- D. Rh Sensitization test
Explanation: ***Indirect Coombs' test*** - The **indirect Coombs' test** (or **indirect antiglobulin test, IAT**) is the **gold standard** for detecting **Rh antibodies** in the **mother's serum**, indicating **Rh sensitization**. - This test detects **free antibodies** circulating in maternal blood that can cross the placenta and attack fetal Rh-positive red blood cells. - A positive result means the mother has developed **anti-D antibodies** against Rh-positive fetal RBCs, which can cause **hemolytic disease of the fetus and newborn (HDFN)**. - Performed at **first antenatal visit**, **28 weeks**, and **after delivery** in Rh-negative mothers to guide **RhoGAM administration**. *Direct Coombs' test* - The **direct Coombs' test** (or **direct antiglobulin test, DAT**) is performed on the **infant's red blood cells** after birth, not the mother's serum. - It detects antibodies **already bound** to neonatal RBCs, confirming if hemolysis is occurring in the newborn. - This does **not diagnose maternal sensitization** but rather assesses the **severity of HDFN** in the affected infant. *Rh Antigen test* - This test determines the **Rh status** (positive or negative) of an individual by detecting the presence of the **D antigen** on red blood cells. - It identifies **who is at risk** (Rh-negative mother with Rh-positive baby) but does **not detect antibodies** or confirm sensitization. - It is a prerequisite screening test, not a diagnostic test for sensitization. *Rh Sensitization test* - This is a **non-specific descriptive term**, not an actual standardized laboratory test. - While the clinical goal is to assess for "Rh sensitization," the **specific test** that accomplishes this is the **indirect Coombs' test**.
Question 2: Anti-D prophylaxis is MOST critically indicated in which of the following situations?
- A. Amniocentesis at 16 weeks
- B. Manual removal of placenta
- C. Intra-uterine transfusion at 28 weeks (Correct Answer)
- D. MTP at 63 days
Explanation: ***Intra-uterine transfusion at 28 weeks*** - **Intra-uterine transfusion (IUT)** is an invasive procedure involving needle insertion into the fetal umbilical vein or peritoneal cavity to transfuse blood (typically O-negative) to treat severe fetal anemia. - This procedure carries a **very high risk of fetomaternal hemorrhage** due to the invasive nature of accessing fetal vessels, with potential for significant mixing of fetal and maternal blood. - The procedure is performed when the fetus is already at risk (Rh alloimmunization complications), and any additional sensitization could worsen the current or future pregnancies. - **Adequate anti-D prophylaxis is absolutely critical** to prevent exacerbation of alloimmunization. *Amniocentesis at 16 weeks* - **Amniocentesis** carries approximately 1% risk of fetomaternal hemorrhage, necessitating anti-D prophylaxis. - This is a standard indication for anti-D prophylaxis (300 mcg in second/third trimester). - The procedure is less invasive than intra-uterine transfusion. *Manual removal of placenta* - **Manual removal of the placenta** is associated with **very high risk of significant fetomaternal hemorrhage** (can exceed 30 mL of fetal blood) due to direct uterine manipulation and placental separation. - This is one of the **most important postpartum indications** for anti-D prophylaxis. - While extremely critical, this is a postnatal event, whereas IUT represents an ongoing high-risk antenatal situation in an already sensitized pregnancy scenario. *MTP at 63 days* - **Medical Termination of Pregnancy (MTP)** at 63 days (9 weeks) involves risk of fetomaternal hemorrhage, though typically smaller volumes due to early gestational age. - Anti-D prophylaxis (50 mcg for first trimester) is recommended for all Rh-negative women undergoing MTP. - The risk and volume of fetomaternal hemorrhage is generally less than with invasive antenatal procedures or traumatic delivery events.
Question 3: Under the Anaemia Mukt Bharath initiative, mild to moderate anaemia in pregnant women <34 weeks of gestation is treated using:
- A. IM ferric carboxy maltose (FCM)
- B. IV iron sucrose for non-compliance with oral tablets
- C. 2 iron and folic acid tablets OD+IV iron sucrose
- D. 1-2 IFA tablets daily (depending on severity) (Correct Answer)
Explanation: ***1-2 IFA tablets daily (depending on severity)*** - The **Anaemia Mukt Bharat (AMB)** guidelines recommend **oral iron and folic acid (IFA)** supplementation as the primary treatment for mild to moderate anaemia in pregnant women <34 weeks gestation. - **Mild anaemia (Hb 10-10.9 g/dL):** 1 IFA tablet daily (100 mg elemental iron + 500 mcg folic acid) - **Moderate anaemia (Hb 7-9.9 g/dL):** 2 IFA tablets twice daily (total 200 mg elemental iron per day) - Oral IFA is safe, cost-effective, and addresses the underlying nutritional deficiency. *IM ferric carboxy maltose (FCM)* - **Intramuscular (IM) iron** formulations like FCM are generally reserved for cases of severe anaemia, malabsorption, or intolerance to oral iron. - For mild to moderate anaemia, IM iron is not the **first-line treatment** under AMB guidelines due to potential injection site reactions and the effectiveness of oral alternatives. *IV iron sucrose for non-compliance with oral tablets* - **Intravenous (IV) iron sucrose** is indicated for specific situations such as severe anaemia (Hb <7 g/dL), significant malabsorption, documented intolerance, or persistent non-compliance with oral iron. - However, for mild to moderate anaemia, efforts are made to ensure compliance with oral treatment before resorting to **parenteral iron**, particularly given its higher cost and need for administration in a healthcare setting. *2 iron and folic acid tablets OD+IV iron sucrose* - Combining **oral iron tablets with IV iron sucrose** is not recommended for mild to moderate anaemia under AMB guidelines. - This approach would be considered **overtreatment** for mild to moderate anaemia in the absence of severe anaemia or documented failure of oral therapy despite good compliance.
Question 4: What are the criteria for administering Anti-D immunoglobulin postpartum in an Rh-negative female?
- A. DCT positive, Baby Rh +ve
- B. DCT negative, Baby Rh +ve (Correct Answer)
- C. DCT negative, Baby Rh -ve
- D. DCT positive, Baby Rh -ve
Explanation: ***DCT negative, Baby Rh +ve*** * The mother is **Rh-negative** and needs Anti-D immunoglobulin if her baby is **Rh-positive** to prevent sensitization. * A **negative Direct Coombs Test (DCT)** indicates that the mother has not yet developed antibodies against the baby's Rh-positive red blood cells, making Anti-D administration effective for prevention. * *DCT positive, Baby Rh +ve* * If the **DCT is positive**, it means the mother has already formed **antibodies** against the baby's Rh-positive red blood cells (sensitization has occurred). * In this scenario, administering Anti-D immunoglobulin would be **ineffective** as the immune response has already begun. * *DCT negative, Baby Rh -ve* * If the baby is **Rh-negative**, there is no risk of Rh sensitization for an Rh-negative mother. * Therefore, **Anti-D immunoglobulin is not necessary** in this situation. * *DCT positive, Baby Rh -ve* * A **positive DCT** in an Rh-negative mother implies sensitization has occurred, but it would not be due to an Rh-negative baby. * Administering Anti-D immunoglobulin would be **ineffective** and unnecessary if the baby is Rh-negative.
Question 5: Fetomaternal transfusion of fetal RBCs in mother can be detected by: UPSC 08; TN 08; AIIMS 10
- A. Electrophoresis
- B. Indirect Coomb's test
- C. Direct Coomb's test
- D. Betke-Kleihauer test (Correct Answer)
Explanation: ***Betke-Kleihauer test*** - The **Kleihauer-Betke test** (or acid elution test) detects fetal hemoglobin (HbF) in maternal blood. Fetal red blood cells, which contain HbF, are more resistant to acid elution and retain their hemoglobin, appearing stained, while adult red blood cells containing HbA lose their hemoglobin and appear as 'ghost' cells. - This visual differentiation allows for the quantification of **fetomaternal hemorrhage**, which is crucial for determining the appropriate dose of anti-D immunoglobulin in Rh-negative mothers [1]. - This is the **gold standard test** for detecting and quantifying fetomaternal transfusion. *Electrophoresis* - **Hemoglobin electrophoresis** is used to identify and quantify different types of hemoglobin (e.g., HbA, HbS, HbC, HbF) in a blood sample. While it can detect HbF, it is not the primary or most practical method for routinely quantifying the small percentage of fetal cells in maternal circulation in the context of fetomaternal hemorrhage. - It is typically used for diagnosing **hemoglobinopathies** and thalassemias, not for accurately determining the extent of fetomaternal transfusion. *Indirect Coombs test* - The **Indirect Coombs Test** (ICT) detects *antibodies circulating in the serum* that are capable of binding to red blood cells [1]. It is commonly used for **antibody screening** in prenatal care and for cross-matching blood transfusions. - While it can screen for maternal antibodies against fetal red blood cell antigens, it does not directly quantify the volume of fetal blood that has entered the maternal circulation. *Direct Coombs test* - The **Direct Coombs Test** (DCT) detects antibodies *attached directly to the surface of red blood cells*, typically indicating autoimmune hemolytic anemia or a hemolytic transfusion reaction. - It is used to detect antibodies on the infant's red blood cells in cases of **hemolytic disease of the newborn**, but not to quantify fetal cells in the mother's circulation. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of Infancy and Childhood, pp. 469-470.
Question 6: In an Rh-negative mother who has delivered an Rh-positive baby, prophylactic anti-D is indicated for:
- A. If the Indirect Coomb's test (ICT) is negative (Correct Answer)
- B. If the Indirect Coomb's test (ICT) is positive (indicating sensitization)
- C. If the Indirect Coomb's test (ICT) is positive with rising antibody titres
- D. As a routine procedure for all Rh-negative mothers regardless of sensitization status
Explanation: ***If the Indirect Coomb's test (ICT) is negative*** - Prophylactic anti-D immunoglobulin works by **preventing active antibody production** in the mother when her immune system is first exposed to Rh-positive fetal red blood cells. - A **negative Indirect Coombs' test** indicates that the mother has not yet been sensitized and does not have pre-existing anti-Rh antibodies, making her an ideal candidate for prophylaxis. - This is the **key requirement** for anti-D administration to be effective. *If the Indirect Coomb's test (ICT) is positive (indicating sensitization)* - If the ICT is positive, it means the mother has already been **sensitized** and has produced antibodies against Rh-positive blood. - In this scenario, administering anti-D immunoglobulin would be ineffective as the **immune response has already occurred**. *If the Indirect Coomb's test (ICT) is positive with rising antibody titres* - A positive ICT with rising titers signifies that the mother is not only sensitized but also actively producing a **stronger immune response** against Rh-positive blood. - Anti-D immunoglobulin is a **preventative measure**, not a treatment for an active immune response, and would not be beneficial in this case. *As a routine procedure for all Rh-negative mothers regardless of sensitization status* - While anti-D is routinely recommended for non-sensitized Rh-negative mothers, it **must not be given without confirming negative sensitization status**. - Administering anti-D to already sensitized mothers (positive ICT) is ineffective and wasteful, as the immune response has already been established. - The ICT must be performed to **exclude prior sensitization** before prophylactic anti-D is given.
Question 7: A G2P1L1 female presents at 28 weeks of gestation with a 1:4 anti-D titre. What is the most appropriate management option?
- A. MCA Doppler (Correct Answer)
- B. Caesarean section
- C. Induction of labour
- D. Amniocentesis
Explanation: ***MCA Doppler*** - The presence of anti-D antibodies in a pregnant woman indicates **Rh isoimmunization**, which can lead to **hemolytic disease of the fetus and newborn (HDFN)**. - Even though a titre of **1:4 is below the critical threshold** (usually 1:16 or 1:32), any detectable anti-D titre at 28 weeks warrants **fetal surveillance** to detect early signs of fetal anemia. - **Middle cerebral artery (MCA) Doppler** is the **non-invasive gold standard** for detecting fetal anemia by measuring peak systolic velocity (PSV), which increases in anemic fetuses due to hyperdynamic circulation. - Serial MCA Doppler monitoring allows timely intervention if fetal anemia develops, avoiding unnecessary invasive procedures. *Caesarean section* - This is a mode of delivery and would only be considered if there were severe **fetal compromise** or other obstetric indications after proper monitoring and management. - At 28 weeks gestation with a low anti-D titre, immediate delivery is **not indicated** and would result in significant prematurity risks. *Induction of labour* - Induction of labour is a delivery method that would only be planned at term or for specific indications like severe fetal compromise unresponsive to other interventions. - At **28 weeks gestation**, the focus should be on **monitoring and prolonging pregnancy** while ensuring fetal wellbeing, not on delivery. *Amniocentesis* - Historically used to assess **bilirubin levels (ΔOD450)** in amniotic fluid as an indirect measure of fetal hemolysis, but it is an **invasive procedure** with risks (miscarriage ~1%, infection, worsening sensitization). - **MCA Doppler has largely replaced amniocentesis** for initial and serial assessment of fetal anemia due to its non-invasive nature, high sensitivity, and ability to be repeated safely.
Question 8: Consider the following statements regarding pregnancy with Rh isoimmunization: 1. Indirect coombs test is performed in mother 2. Methergin is withheld at delivery of anterior shoulder 3. Middle cerebral artery peak systolic velocity is an accurate method to predict fetal anemia Which of the statements given above are correct?
- A. 1 and 2 only
- B. 2 and 3 only
- C. 1, 2 and 3
- D. 1 and 3 only (Correct Answer)
Explanation: ***1 and 3 only*** - The **indirect Coombs test (IAT)** is performed on the mother's serum to detect **Rh antibodies**, which is essential for diagnosing and monitoring Rh isoimmunization. - **Middle cerebral artery peak systolic velocity (MCA-PSV)** >1.5 MoM is a non-invasive and highly accurate ultrasound method to predict moderate to severe **fetal anemia** in Rh-isoimmunized pregnancies, guiding the need for intrauterine transfusion. - Statement 2 is **incorrect**: While minimizing fetomaternal hemorrhage is important in Rh isoimmunization, there is **no specific evidence-based guideline** that Methergine should be routinely withheld at delivery of the anterior shoulder in Rh-negative mothers. The focus is on **timely Anti-D administration** (within 72 hours postpartum) rather than avoiding specific uterotonics. *1 and 2 only* - Statement 1 is correct, but statement 2 is incorrect. - Methergine (methylergonovine) is not specifically contraindicated in Rh isoimmunization; its main contraindications include **hypertension and preeclampsia** due to vasoconstrictive effects. - Prevention of Rh sensitization focuses on **Anti-D immunoglobulin administration**, not withholding uterotonics. *2 and 3 only* - Statement 3 is correct regarding **MCA-PSV** accuracy for fetal anemia detection. - Statement 2 is incorrect: Methergine withholding is not a standard practice specifically for Rh isoimmunization management. *1, 2 and 3* - Statements 1 and 3 are correct. - Statement 2 is incorrect: There is no established protocol to withhold Methergine at delivery of the anterior shoulder specifically for Rh isoimmunization. Management focuses on **preventing sensitization through Anti-D prophylaxis**, **monitoring with antibody titers**, and **detecting fetal anemia via MCA-PSV**, not on avoiding specific uterotonics.
Question 9: Which one of the following statements regarding Rh isoimmunization is correct? 1. Liley's chart identifies anemia better than middle cerebral artery Doppler 2. Indirect Coombs test is positive in mother 3. Baby is at risk of developing anemia 4. Direct Coombs test is positive in baby
- A. 1, 2 and 4
- B. 2, 3 and 4 (Correct Answer)
- C. 1, 3 and 4
- D. 1, 2 and 3
Explanation: ***2, 3 and 4 are correct*** - The **indirect Coombs test** identifies **anti-Rh antibodies** in the mother's serum, indicating she has been sensitized to Rh antigens. - The baby is at risk of developing **hemolytic anemia** due to transplacental passage of maternal anti-Rh antibodies, which destroy fetal red blood cells. - The **direct Coombs test** detects **anti-Rh antibodies** coating the baby's red blood cells, confirming immune-mediated hemolysis in the neonate. *1, 2 and 4* - **Middle cerebral artery (MCA) Doppler** is the preferred non-invasive method for detecting **fetal anemia** because it directly assesses blood flow velocity, which increases with anemia. - While Liley's chart was historically used to assess amniotic fluid bilirubin levels (a breakdown product of hemolysis), **MCA Doppler** is now considered more accurate and less invasive for identifying fetal anemia. *1, 3 and 4* - **Liley's chart** analyzes the **bilirubin levels** in amniotic fluid, which is an indirect indicator of hemolysis and fetal anemia. However, **MCA Doppler** is a more direct and accurate method for assessing fetal anemia. - The indirect Coombs test on the mother is a crucial diagnostic step in Rh isoimmunization, identifying the presence of **maternal antibodies**. *1, 2 and 3* - The **direct Coombs test** on the baby is essential for confirming **hemolytic disease of the newborn**, as it detects antibodies bound to the infant's red blood cells. - **Liley's chart** is less accurate than **MCA Doppler** for assessing fetal anemia, as Doppler measurements provide a real-time assessment of fetal blood flow.
Question 10: One day after delivery, an African American female newborn develops yellow discoloration of the eyes. She was born at term via uncomplicated vaginal delivery and weighed 3.4 kg (7 lb 8 oz). Her mother did not receive prenatal care. Examination shows scleral icterus and mild hepatosplenomegaly. Laboratory studies show: Hemoglobin 10.7 g/dL Reticulocytes 3.5% Maternal blood group O, Rh-negative Fetal blood group A, Rh-negative Serum bilirubin, total 6.1 mg/dL Serum bilirubin, direct 0.4 mg/dL Which of the following is the most likely cause of this patient's condition?
- A. Transfer of Anti-A antibodies (Correct Answer)
- B. Binding of Rhesus immune globulins
- C. Viral infiltration of the bone marrow
- D. Polymerization of deoxygenated hemoglobin
Explanation: ***Transfer of Anti-A antibodies*** - The mother is **blood group O**, which naturally produces **anti-A and anti-B antibodies**. Since the infant is **blood group A**, these maternal *IgG antibodies* can cross the placenta and cause **hemolysis** in the infant [1], [2]. - This leads to **neonatal jaundice** (due to increased bilirubin from hemolysis) and **anemia** (hemoglobin 10.7 g/dL), with a compensatory **reticulocytosis** (3.5%) [1]. The **splenomegaly** can also be attributed to increased red blood cell destruction [3]. *Binding of Rhesus immune globulins* - The mother is **Rh-negative** and the infant is also **Rh-negative**. Therefore, **Rh incompatibility** is not the cause of the hemolytic disease in this newborn [1]. - **Rhesus immune globulin** is given to **Rh-negative mothers** to prevent alloimmunization against **Rh-positive fetal red blood cells**, which is not relevant here. *Viral infiltration of the bone marrow* - While **viral infections** can cause **hepatosplenomegaly** and **anemia**, they typically suppress red blood cell production, leading to a **low reticulocyte count**, not the **elevated reticulocyte count** seen in this infant. - **Jaundice** associated with viral infections is usually due to **hepatitis** (elevated direct bilirubin), which is not the primary pattern shown here [3]. *Polymerization of deoxygenated hemoglobin* - This process is characteristic of **sickle cell disease**, where **sickle hemoglobin (HbS)** polymerizes, causing red blood cell sickling. - While it can cause **anemia** and **splenomegaly**, it does not typically present as **acute severe jaundice** in the newborn period and is not associated with **ABO incompatibility**.
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free